Poly(ADP-ribosyl)ation is a posttranslational protein modification carried out by a family of enzymes referred to as poly(ADP-ribose) polymerases (PARPs). It has been proposed that the broad nuclear distribution of PARPs may allow them to modulate gene expression in addition to their more accepted role as DNA repair mediators. The role of poly(ADP-ribosyl)ation during oogenesis and folliculogenesis is unknown. Here we found that when 3-to 4-wk-old mice were injected with 5-amninoisoquinolinone, a water soluble inhibitor of poly(ADPribosyl)ation, it leads to considerably increased oocyte numbers and a dramatic increase in primordial follicle numbers. Furthermore, we show that inhibition of poly(ADP-ribosyl)ation leads to an increased expression of specific genes and pathways in mouse ovaries, in particular, transforming growth factor superfamily members. Our results demonstrate that poly(ADPribosyl)ation, is important in oogenesis and folliculogenesis, and it may have a differential role in regulating gene expression, DNA repair, and apoptosis. The novel function of poly(ADPribosyl)ation in oogenesis and folliculogenesis sheds light on the alternative role that DNA repair mediators may play in cellular development and differentiation.
INTRODUCTION
Oogenesis and folliculogenesis are accompanied by epigenetic modifications to DNA and chromatin remodeling [1, 2] . A number of specific genes [3] [4] [5] [6] [7] and gene families are expressed by ovarian somatic cells and oocytes in a developmental, stage-related manner and function as intraovarian regulators of folliculogenesis, including growth factors, many which belong to the transforming growth factor-beta (TGF-beta) superfamily [8] , apoptosis factors [9] , and more recently even circadian genes [10] . The factors that regulate these events and the possible link between gene regulation and chromatin remodeling are still unclear, limiting our understanding of the regulation of this process.
One of the most drastic posttranslational modification of proteins in eukaryotic cells is poly(ADP-ribosyl)ation, catalyzed by a family of enzymes termed poly(ADP-ribose) polymerases (PARPs) [11] . PARPs catalyze the formation of poly(ADP-ribose) (PAR) chains by transferring ADP-ribose from NAD þ onto acceptor proteins or PARPs themselves [12] . PAR has a fast turnover rate, due to rapid degradation by PAR glycohydrolase (PARG). PARG is the major enzyme responsible for PAR breakdown, and its absence leads to increased sensitivity to cytotoxicity and early embryonic lethality [13] . Poly(ADP-ribosyl)ation of nuclear proteins has been implicated in the epigenetic regulation of chromatin structure and transcription [14, 15] . PARP1 is responsible for over 90% of poly(ADP-ribosyl)ation activity following DNA conformation change [16] . The deletion of PARP1 leads to hypersensitivity to both alkylating agents and ionizing radiation, while Parp1 and Parp2 double knockout mice are embryonically lethal [17] .
Poly(ADP-ribosyl)ation has been classically shown to be a pivotal molecule in DNA repair, apoptosis, and necrosis. Upon DNA damage, PARP1 is rapidly automodified and catalyzes the poly(ADP-ribosyl)ation of nuclear acceptor proteins, such as histone H1 and H2B, which leads to the relaxation of chromatin structure [18] . Genome instability would be an overwhelming problem for cells and organisms if it were not for DNA repair [19] . Nowhere is DNA repair more important than in maintaining the genomic integrity of the gametes. An efficient DNA repair system(s) is therefore indispensable for policing mammalian oogenesis and folliculogenesis so that competent oocytes can develop [20] .
PARP1 is also being increasingly implicated in more complex events such as a previously uncharacterized nucleosome-binding property that promotes the formation of compact, transcriptionally repressed chromatin structures [14] and as a regulated promoter-specific exchange factor required for activation of specific neurogenic gene programs [21] . Therefore, in addition to its classical role as a DNA repair mediator, PARP1 also functions both as a structural component of chromatin and a modulator of chromatin structure through its intrinsic enzymatic activity.
The above multipurpose attributes of PARP1 have led to the proposition that the broad distribution of PARPs in the nucleus allows them to function in gene activation and transcription in addition to their more accepted role as DNA repair mediators [15] . The intricate gene regulation necessary for oogenesis and folliculogenesis to proceed and a strong need to police DNA integrity make poly(ADP-ribosyl)ation and PARP1 strong candidates for participating in this process. Here we present evidence that poly(ADP-ribosyl)ation occurs extensively throughout follicular development and that it may be strongly implicated in regulating gene expression during mammalian oogenesis and folliculogenesis.
MATERIALS AND METHODS

Animals and Treatments
Three-to four-wk-old (young) and retired breeding (old, .9 mo) 129S6/ SvEv female mice were purchased from Taconic Farms Inc. (Hudson, NY), while 129S/Parp1 À/À mice were purchased from Jackson Laboratory (Bar Harbor, ME). All the animal procedures were performed under an approved protocol in accordance with the guidelines of the animal care committee of the Yale University School of Medicine.
To investigate the role of poly(ADP-ribosyl)ation on oogenesis, we treated mice with 5-amninoisoquinolinone (5-AIQ; Alexis, San Diego, CA), a water soluble inhibitor of poly(ADP-ribosyl)ation [22] . Mice were allocated into two treatment groups.
Saline or 5-AIQ plus ovarian stimulation group. Young, old, and Parp1
À/À mice were administered an intraperitoneal injection of saline or 5-AIQ at a dose of 3 mg/kg every 24 h starting from Day 1 to Day 12, plus 5 international units (IU) of equine chorionic gonadotropin (eCG; Sigma, St. Louis, MO) at Day 10 and 7.5 IU of human chorionic gonadotropin (hCG; Sigma) at Day 12. Mice were euthanized 18-20 h after the hCG administration. Oviducts were removed in a drop of Hepes-buffered HTF (human tubal fluid) medium with hyaluronidase (80units/ml) and 5mg/ml human serum albumin (HSA) (SAGE Media, Trumbull, CT). Oocyte-cumulus complexes (OCCs) were released from the oviduct by tearing the ostium of the oviduct. After 30-45 sec, the denuded oocytes from the OCCs were collected by using a fine-bore glass pipette and washed through drops of Quinn advantage medium with Hepes (SAGE Media) plus 5 mg/ml HSA. Oocytes were then counted. Saline or 5-AIQ group. Only 3-to 4-wk-old mice were used in this group. Mice were treated with saline or 5-AIQ at a dose of 3 mg/kg every 24 h for 9 days. Ovarian tissue samples were collected 4 h after the Day 9 injection. One ovary was prepared for immunostaining as described below and the opposite ovary from each mouse was used to prepare RNA for real-time PCR analysis or protein for Western blots as described below. For the microarray assay, two ovaries from each mouse were pooled together for RNA isolation. The number of mice used in different groups is shown in the figure legends.
Follicle Counting
Mouse ovaries were fixed in 4% paraformaldehyde for 16 h and embedded with paraffin. Serial sections (6 lm) were cut from the paraffin blocks. Every fifth section throughout the entire ovary was stained with hematoxylin and eosin (Sigma) and follicles with a nucleus present in the oocyte were counted in a blinded fashion: all the sections were prepared by one author (H.Q.) and were blind to the reader (K.G.). The follicles were classified as primordial, primary, preantral, and antral. The number of follicles per ovary were estimated by multiplying with a correction factor of five and dividing by the total section number of each ovary as previously described [23] .
Immunohistochemistry and Immunofluorescence
Paraffin sections (6 lm) of the ovaries were deparaffinized in xylene and rehydrated in graded alcohol. Antigen retrieval was performed by boiling the sections in 0.1 M sodium citrate, pH 6.0, followed by 0.2% Triton X-100 in PBS for 10 min. For immunohistochemistry, the slides were treated with 3% H 2 O 2 in deionized water for 10 min to quench endogenous peroxidase activity. After blocking with 10% normal serum for 1 h at room temperature, sections were incubated with primary antibody overnight at 48C. The following primary antibodies (1:100) were used: PARP1 and BMP15 (R&D, Minneapolis, MN), PAR (Trevigen, Gaithersburg, MD), cleaved-PARP1 (Abcam, Cambridge, MA), and Grem1 and Per1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). The specimens were then incubated with biotinylated secondary antibodies for 30 min at 378C followed by incubation with ABC reagent (VECTASTAIN Elite ABC kit; Vector Laboratories, Burlingame, CA) for 30 min at 378C. The sections were developed using a VIP substrate kit (Vector Laboratories) for 2-10 min and counterstained by methyl green (Vector Laboratories) or hematoxylin (Sigma). For immunofluorescence, the sections were incubated with fluorescent-conjugated secondary antibodies for 1 h at room temperature. Double labeling was performed as described above using two antibodies raised in different species and two secondary antibodies with different fluorochromes. The corresponding secondary antibodies were used: biotin-labeled anti-rabbit, anti-goat (1:1000) (Pierce, Rockford, IL), horseradish peroxidase (HRP)-labeled anti-biotin (Cell Signaling, Danvers, MA), and Texas Red-and CY2 conjugated anti-biotin, anti-rabbit (1:400) (Jackson ImmunoResearch Laboratories, West Grove, PA). Counterstaining for immunofluorescence was performed using 4 0 -6-diamidino-2-phenylindole (DAPI) (Sigma). Controls were performed with all the sections by omitting the primary antibody.
Immunohischemistry images were taken with an Axioplan 2 Imaging Zeiss microscope and AxioVision Rel 4.6 software. Immunofluorescent images were taken with an Olympus fluorescent microscope equipped with a CCD camera and IPlab capture software.
Western Blot Analysis
Ovarian samples were snap frozen in liquid nitrogen and stored at À808C. They were lysed using a CelLytic-MT mammalian tissue lysis/extraction reagent (Sigma) after adding a protease inhibitor cocktail (Roche, Indianapolis, IN). Protein concentration was measured using the Bradford assay (Bio-Rad, Hercules, CA). The samples were then subjected to 4-15% SDS-PAGE and transferred to polyvinylidene fluoride (Bio-Rad); 5% milk was used for blocking; and the corresponding primary antibodies were added: PARP1 (1:500), cleaved-PARP1 (1:1000), and PAR (1:500) (BD Biosciences, San Jose, CA), and b-actin (1:5000) (Abcam, Cambridge, MA). The HRP-labeled secondary antibody incubation was performed at room temperature for 1 hr. Equal loading was confirmed using an actin marker protein.
Microarray and Real-Time PCR
Total RNA of ovaries was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The extracted RNA was resuspended in dietylpryocarbonate-treated water and purified with a RNeasy Mini Kit (Qiagen, Valencia, CA). The RNA was quantified by absorption at 260 nm/280 nm and stored at À808C until use.
Microarray. The RNA quality was determined by the gel electrophoresis pattern, which revealed two major bands of 28S and 18S RNA. The RNA quality was further assessed by Agilent bioanalyzer (Agilent Technologies, Palo Alto, CA). The RNA integrity numbers were all above 9.9. Labeled cDNA was prepared and subsequently hybridized to Mouse Genome 430 2.0 Array (Affymetrix), which consists of 45 000 probe sets used to analyze the expression level of over 39 000 transcripts and variants from over 34 000 wellcharacterized mouse genes. Hybridization and scanning were performed by the Affymetrix Resource facility at Yale University (http://keck.med.yale.edu/ affymetrix). The microarray data analysis consisted of differentially expressed genes between the saline and 5-AIQ groups (N ¼ 4/group). The analysis of clustering and biological pathways was also performed by the Keck Facility biostatistics group. Concurrently, with the preparation of mouse ovaries, a further four mice were included in the same injection series, but these mice were not sacrificed on Day 9 but went on to receive eCG and hCG injections. These mice were euthanized after the HCG injection (as described above) and confirmed that oocyte numbers were significantly improved in the AIQ group.
Real-time PCR. RNA template was reverse transcribed with an Omniscript Reverse Transcription kit (Qiagen) using oligo-dT. Each 25-ll real-time PCR reaction contained 12.5 ll of 2x SybrGreen supermix (Bio-Rad), 0.4 lM of each primer, and 1 ll of template cDNA, and was performed in an iCyclerIQ PCR system (Bio-Rad). Each sample was assayed in triplicate, and each experiment was repeated three times. Primers were chosen and tested by melting-curve analysis and standard curve (threshold cycles versus copy number). The DDCt (cycle threshold) method was used to calculate gene expression levels. The following primers were used for real-time PCR: (1) Parp1 forward: GCAGAGCCTGGTGAAGTGGTG, reverse: GACGTGTG CAGAGTGTTCCAG; (2) Bmp15 forward: GTAAGGCCTCCCAGAGGTTC, reverse: CCACATGGCAGGAGAGATGG; (3) Bmpr1b forward: CGACCTCGGTACAGCATTG, reverse: GCTATTGTCCTTTGGACCAG; (4) Per1 forward: CTCAGGTATTTGGAGAGCTGCAA, reverse: TTGCTGACGACGGATCTTTCT; (5) Grem1 forward: CACTCGTCCA CAGCGAAGAAC, reverse: GGGTCTGCTCAGAGTCATG; and (6) Actb forward: GACCTCTATGCAACACAGT, reverse: TTGCTGATCCA CATCTGCT. The data was normalized to b-actin. The ratio of the gene of interest to b-actin for the control ovary was considered to be equal to 1.0.
Statistical Analyses
The results are presented as means 6 SEM. The t-test was used to examine the results from the treated and control groups, and significance was set at P , 0.05.
RESULTS
The Expression of Poly(ADP-ribose) and PARP1 During Oogenesis and Folliculogenesis
To investigate whether poly(ADP-ribosyl)ation plays a role in the ovary, we first explored the expression patterns of both POLY(ADP-RIBOSYL)ATION AND OOGENESIS PAR and PARP1 during oogenesis and folliculogenesis. Immunohistochemical analysis of mouse ovaries revealed that poly(ADP-ribosyl)ation occurs extensively throughout mouse follicle development (Fig. 1) . PARP1 was expressed in the nuclei of oocytes throughout follicular development from the primordial to the secondary follicle stages (Fig. 1) . In contrast to the expression pattern in granulosa cells of PAR, PARP1 was present in the majority of granulosa cells surrounding the developing oocyte in the postprimary follicle stages (Fig. 1) .
Inhibition of Poly(ADP-ribosyl)ation in Mouse Ovaries
To determine whether poly(ADP-ribosyl)ation is critical for folliculogenesis, we interfered with the poly(ADP-ribosyl)ation of mouse ovaries by using 5-AIQ, a well-characterized inhibitor of poly(ADP-ribosyl)ation [22] . Confirmation of inhibition of poly(ADP-ribosyl)ation by 5-AIQ is shown in Supplemental Figure S1 (all supplemental data are available online at www.biolreprod.org). 5-AIQ is a competitive inhibitor of PARP1 and PARP2 and therefore blocks PAR in general, that is, it is not a particular PAR polymerase. When applying the regime described in the Materials and Methods followed by ovarian stimulation, a stimulatory effect of 5-AIQ was revealed as we consistently harvested a significantly greater number of mature oocytes compared to control (Fig. 2) . Interestingly, the oocyte number was dependent on the 5-AIQ doses as the injection of 5-AIQ at 1.2mg/kg and 3mg/kg significantly increased the number of ovulated oocytes by 32% and 74%, respectively, when compared to control. Furthermore, we also injected seven 6-to 8-wk-old mature female mice with either saline or 5-AIQ for 9 days and then mated them to fertile males. Two series of seven matings were established and the females were allowed to deliver. The mean number of fetuses (6 SD) delivered by treated females was significantly higher (P , 0.05) in two consecutive matings for the 5-AIQ treated mice (N ¼ 14: 10.07 6 2.97) compared to controls (N ¼ 14: 5.92 6 2.47). In addition, the fetuses showed no distinguishable signs of fetal abnormalities.
To test whether the stimulatory effect of 3 mg/kg 5-AIQ on folliculogenesis was mediated by PARP, we tested the effect of 5-AIQ on Parp1 À/À mice by using the same protocol that was effective on wild-type mice. We found no significant difference between control and 5-AIQ-treated Parp1 À/À mice (Fig. 3a) . This strongly indicated that PARP1 is implicated in the observed increase in oocyte numbers. To further investigate the stimulatory effect, we also tested whether the effect of 5-AIQ was evident in older postpubertal mice (.9 mo old). The results showed that after treatment with 5-AIQ, older mice also increased the number of ovulated oocytes by 27% (P , 0.05) (Fig. 3b) .
To examine at what stage of folliculogenesis the increase in oocyte number was initiated, we blindly assessed the number and types of follicles in the two different treatment groups and found that the primordial follicles were dramatically increased after 5-AIQ treatment (Fig. 4) .
In addition to testing with 5-AIQ, we also performed a closer examination of the breeding efficiency of our Parp1
À/À mice are not infertile [24] . A recent more extensive examination of their breeding by Yang et al. [25] failed to report a significant difference whereby controls had an average litter size of 5.9 6 0.7 pups per litter compared to 5. old) found that in 10 confirmed pregnant females the knockout mice had a significantly lower number of pups delivered (P , 0.05) (Supplemental Fig. S2 ). The possible role of PARP2 in female fertility requires further investigation.
The Role of Poly(ADP-ribosyl)ation in Apoptosis
To investigate whether PARP1-mediated apoptosis was inactivated in the 5-AIQ-treated ovaries after inhibition of poly(ADP-ribosyl)ation, the expression of cleaved-PARP1 in 3-to 4-wk-old mouse ovaries was compared to control and found to be decreased. This implied that the apoptotic pathway that involves PARP1 is reduced in the 5-AIQ-treated ovaries (Fig. 5a ). In contrast, PARP1 expression in the 5-AIQ-treated mice was not visibly altered; however, real-time PCR analysis showed that the gene expression of Parp1 was elevated by 44% compared to the saline group (Fig. 5b) . Immunofluorescent double staining showed that PARP1 was present in the nuclei of all the stages of oocytes and surrounding granulosa cells, while cleaved-PARP1 was localized in the cytoplasm of oocytes from the primordial to the late follicle stages and was especially abundant in the granulosa cells in the antral follicles (Fig. 5c ).
Gene Expression in Mouse Ovaries after the Inhibition of Poly(ADP-ribosyl)ation
To further investigate which genes were involved in the poly(ADP-ribosyl)ation pathway in the mouse ovary, we examined gene expression in mouse ovaries from the saline and 5-AIQ groups by microarray analysis. The microarray pathway analysis file is included as Supplemental Table S1 . Pathway analysis was performed independently by the Yale Keck facility and showed significant differences in major gene pathways in ovarian tissue collected after 9 days of injection with 5-AIQ compared to controls (Table 1) . Of note, the microarray analysis showed significant differences in a number of key genes related to the TGF-beta pathway, including Bmp15, Bmpr1b, Grem1 (gremlin 1), and Per1. The expression of these genes and their subsequent proteins in ovarian tissue were confirmed by quantitative PCR (Fig. 6a) and immunohistochemical staining (Fig. 6b) .
DISCUSSION
Reproduction and Poly(ADP-ribosyl)ation
In this study, we have provided convincing evidence that poly(ADP-ribosyl)ation is implicated in mammalian folliculogenesis and oogenesis. We have shown that there is a clear immunostaining pattern in the mouse ovary and a temporaland spatial-specific expression of both PAR and PARP1. Down-regulating poly(ADP-ribosyl)ation led to a significant increase in the number of oocytes in prepubertal and pubertal females and increased numbers of fetuses; this effect was erased in the absence of PARP1. Furthermore, the increase in oocyte and fetal numbers appears to be a result of an increased presence of primordial follicles, possibly as a result of decreased apoptosis. Finally, down-regulating poly(ADPribosyl)ation drives the expression levels of a host of ovarian-specific genes, in particular, members of the TGF-beta family, that may favor increased folliculogenesis and oogenesis.
A number of studies have tentatively linked poly(ADPribosyl)ation with reproduction. PARP1 is associated with the DNA-binding domain of the progesterone receptor [26] and regulates the transcriptional activities of steroid receptors [27] . It has also been shown that a topoisomerase IIb and PARP1 complex can be recruited in response to estradiol E 2 [28] . Progesterone has also been found to stimulate the expression of PARP at the transcriptional level and DNA repair-related poly(ADP-ribosyl)ation in ovarian surface epithelial cells after ovulation through a receptor-mediated pathway [28, 29] . More recently, Yang et al. [25] showed that in the metaphase II stage oocyte PARP1 is required for the regulation of centromere structure and that lack of PARP1 function during oogenesis predisposes the female gamete to genome instability. Morin et al. [30] also found that poly(ADP-ribosyl)ation protects maternally derived histones from proteolysis after fertilization. A recent study also demonstrated that poly(ADP-ribosyl)ation presents and functions during mouse preimplantation development, and failure of PAR metabolism causes mouse embryo lethality [13] . Finally, poly(ADP-ribosyl)ation has also been 
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implicated in the process of chromatin remodeling during spermiogenesis in mammals [31] [32] [33] , and PARP2 was shown to contribute to the fidelity of male meiosis I and spermiogenesis [34] . The present study complements the above findings in showing that inhibition of the poly(ADP-ribosyl)ation pathway has significant implications in altering follicle and oocyte numbers in the mouse ovary.
Inhibition of Poly(ADP-ribosyl)ation Stimulates Folliculogenesis
When the stimulatory effect of 5-AIQ on follicle development was assessed in vivo, the results showed that inhibition of poly(ADP-ribosyl)ation by 5-AIQ appeared to be mediated by the dramatically increasing mouse primordial follicle number.
dent ovary tissue lysates from saline and AIQ groups were analyzed by immunoblotting using antibodies against PARP1, cleaved-PARP1, and b-actin. Each group was normalized to b-actin. Note that after the 5-AIQ treatment, the intensity of cleaved-PARP1 in the AIQ group decreased compared with the saline group (*P , 0.05). Each group represents mean 6 SEM (N ¼ 4). The expression of PARP1 showed no difference (data not shown). The same density of b-actin indicated an equal amount of sample loading. b) Real-time PCR showed the expression of PARP1 significantly increased after AIQ treatment (*P , 0.01). Saline group, N ¼ 12; AIQ group, N ¼ 14. Each group represents mean 6 SEM. c) Ovarian sections were subjected to double immunofluorescence staining. From left to right, the first column shows that PARP1 was located in the nuclei of oocytes in all the different stages of the follicles. The second column shows that cleaved-PARP1 is located in the cytoplasm of oocytes in all the stages. The third column shows nuclei staining with DAPI. The right column shows the merged color images of the three left-most columns (green: PARP1; red:cleaved-PARP1; blue: DAPI). TABLE 1. Pathway analysis showing significant differences in major gene pathways in ovarian tissue collected after 9 days of injection with 5-AIQ compared to controls.
Gene pathways significantly different in 5-AIQ treated ovaries
Significance Genes included in analysis
Ovarian infertility genes (GenMapp) 0.014 Bmpr1b(1422872_at), Cdkn1b(1419497_at), Cyp19a1(1449920_at), Esr2(1426103_a_at), Fshr(1450810_at), Lhcgr(1450192_at), Mlh1(1417360_at), Nrip1(1418469_at, 1454295_at)Prlr(1448556_at, 1437397_at), Smad3(1450471_at), Smad4(1444205_at) Adipocytokine signaling pathway (KEGG) 0.015 Acsl1(1423883_at), Acsl3(1428386_at), Acsl4(1451828_a_at), Adipoq(1422651_at), Camkk2(1424474_a_at, 1424475_at), Ikbkg(1450161_at), Irs2(1443969_at), Jak1(1433804_at), Jak3(1423021_s_at), Mapk8(1420931_at), Pck1(1423439_at), Ppara(1449051_at), Ptpn11(1427699_a_at), Slc2a4(1415958_at), Tnfrsf1b(1448951_at) Heparan sulfate biosynthesis (KEGG) 0.015
The lack of action when using 5-AIQ on Parp1 À/À mice indicated that this effect was mediated via PARP1. Recent studies have shown that PARP1 in addition to its role in policing genome integrity also has the ability to regulate gene activation and transcription through modulating chromatin structure [14, 15, 21, 28] . Ju et al. [28] have shown that the poly(ADP-ribosyl)ation activity of PARP1 was necessary to transcriptionally activate downstream genes. Here, we show that oogenesis and/or folliculogenesis are triggered by PAR inhibition, but are dependent on PARP1, since Parp1 À/À mice failed to present the same phenotype upon PAR inhibition (Supplemental Fig. S3 ). Interestingly, although PARP1 protein expression did not seem to be altered, a significant increase in gene expression was observed. A recent study by Yang et al. [25] has demonstrated that PARP1 function is essential in the recruitment of BUB3 to centromeric heterochromatin in mammalian oocytes and underscored a critical role for PARP1 in the regulation of centromere structure and function and the control of proper chromosome segregation and maintenance of genome stability in the female gamete. In the current scenario, it could be argued that increased Parp1 gene expression was driving the maintenance of the female gamete.
Inhibition of Poly(ADP-ribosyl)ation by AIQ Alters Ovarian Gene Expression
Further evidence of a direct effect on gene regulation was shown in the microarray and real-time PCR analysis of ovaries from 3-to 4-wk-treated mice. The gene pathway analysis results showed that significant differences were evident in a number of key pathways, including that of key ovarian infertility genes and the TGF-beta-signaling pathway (Table  1) . Many TGF-beta superfamily members have been found to be specifically expressed by ovarian somatic cells and oocytes in a developmental, stage-related manner and function as intraovarian regulators of folliculogenesis [8] . Obviously perturbation of key members of this family has a profound effect on oocyte development, and this study indicates that the poly(ADP-ribosyl)ation pathway is implicated. How necessary this relationship is needs further examination. Recently, mounting evidence has shown that TGF-beta superfamily members serve as key regulators of follicle development in mammals [8] . Bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) are two germ cellspecific members of the TGF beta superfamily [35] [36] [37] . Interestingly, both of these factors may play crucial roles in FIG. 6. a) Real-time PCR showing the expression of the TGF-beta-signaling pathway genes Bmp15, Bmpr1b, Per1, and Grem1. Expression of each gene was normalized to a housekeeping gene (actin). The normalized expression of control ovaries (saline group) was set to 1. Bmp15 and Bmpr1b increased after 5-AIQ treatment and Per1 and Grem1 decreased, which confirmed the results from the microarray. b) Immunohistochemistry was used to show BMP15, PER1, and GREM1 protein expression in different stages of mouse follicles. Bars ¼ 40 lm.
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determining folliculogenesis, ovulation rate, and litter size in sheep and mice. Reviews by Liao et al. [38] and Moore et al. [39] discussed how the physiological, cellular, and molecular roles of BMP15 and GDF9 could potentially link these oocytesecreted factors to the species-specific determination of ovulation quota and litter size in mammals. In relation to our study, Ku et al. [40] found that the chromatin-modifying enzyme PARP1 up-regulates transcription of BMP-target genes by forming a complex with a cofactor of BMP-specific signal transducers. Other candidates identified by the microarray include Gremlin 1, which was down-regulated and is interestingly an antagonist of BMPs [41] . Another interesting gene that was found to be down-regulated in expression was period 1 (Per1), a clock gene involved in circadian rhythms. Little is known about this gene; however, it has been localized to the oocyte in the mouse ovary but a function has not been determined [42] . Interestingly, a recent study has indicated that in the ruminant ovary, period 1 does not appear to be involved in the primordial to primary follicle transition, regulation of the ovarian cycle, or prolificacy in ruminants [43] . The numerous gene expression pathways identified in the current study provides potential leads for further studies aimed at investigating the functional significance of PARP in the ovary.
Poly(ADP-ribosyl)ation and Apoptosis in the Ovary
During caspase-dependent apoptosis, PARP1 is cleaved into two fragments of 24 kDa and 89 kDa (p89 and p24) by execution caspases 3 and 7. The catalytic site and the automodification domain are found in p89, while the DNAbinding domain with the zinc fingers is found in p24. The cleavage of PARP1 is considered a distinct marker of apoptosis [11] . The main reason for PARP1 inactivation seems to be the preservation of the cellular ATP necessary to accomplish apoptosis because this process is energy dependent and therefore avoids a necrotic death. PARP1 cleavage may be important for the inhibition of DNA repair, specific gene transcription, and other cellular processes that are not needed anymore for a dying cell. PARP1 was evident in the cleaved form in normal mouse ovaries, whereas in the 5-AIQ ovaries, the cleaved form was decreased, implying that the apoptotic pathway that involves PARP1 is reduced in the poly(ADPribosyl)ation-inhibited ovaries. Given that cleaved PARP1 was shown not only in oocytes of primordial follicles, but also in granulosa cells, a more detailed analysis is needed on the temporal and spatial presence of cleaved PARP1 and other apoptotic markers in the 5-AIQ-treated mice.
Little is known about the role of PARP1 in the apoptosis pathway during oogenesis, although Ghafari et al. [44] have shown that in prenatal mice there are lower proportions of oocytes positive for cleaved PARP1 and/or both cleaved PARP1 and TUNEL among oocytes from p53 heterozygous and knockout fetal ovaries than wild-type.
It has previously been proposed that DNA repair is only one manifestation of a more global role for PARP1 and that its broad distribution in the nucleus can also allow it to function on gene activation and transcription [15, 21] by modulating chromatin structure [14] and puffing repressed chromatin [15] . With this in mind, further mechanistic examination is needed to understand the role of poly(ADP-ribosyl)ation in the ovary. In particular, a greater understanding is needed in how 1) inhibition of the poly(ADP-ribosyl)ation pathway may alter the expression of PARP1-specific gene pathways that affect ovarian function and 2) inhibition of the poly(ADP-ribosyl)-ation down-regulates PARP1-mediated apoptosis, which may be rescuing follicles in the ovary. Numerous questions, however, remain as to the mode of action of the poly(ADPribosyl)ation inhibitor. Although 5-AIQ has been classically used as an inhibitor of poly(ADP-ribosyl)ation, we cannot rule out that it is acting via other mechanisms to stimulate or maintain follicular numbers and improve oocyte numbers. Numerous studies have now suggested that NAD þ and NADH mediate multiple major biological processes, including calcium homeostasis, energy metabolism, mitochondrial functions, cell death, and aging (reviewed by [45, 46] ). It appears that most of the components in the metabolic pathways of NAD þ and NADH, including poly(ADP-ribose), ADP-ribose, cyclic ADPribose, O-acetyl-ADP-ribose, nicotinamide, and kynurenine, can produce significant biological effects and that oogenesis and folliculogenesis are also implicated in this. Confirmation of a more specific action by using other poly(ADP-ribosyl)ation inhibitors is crucial, especially in determining their temporal action in the down-regulation of PARP1. Recently, a number of more specific PARP inhibitors are being assessed in the treatment of cancer [47] . The implication of other PARP family members may also prove crucial to understanding the role of poly(ADP-ribosyl)ation in this process.
In conclusion, in this study we have shown that poly(ADPribosyl)ation is strongly implicated in oocyte development. We provide the first evidence that inhibition of a poly(ADPribosyl)ation pathway can enhance both primordial follicle and oocyte numbers, shedding an alternative light on the role that DNA repair pathways may play in cellular development and differentiation. The multiple roles of gene regulation, DNA repair, and apoptosis that poly(ADP-ribosyl)ation and its mediators play here may have implications in other cellular processes, well beyond gametogenesis.
